Efficacy of the Rho-kinase Inhibitor Ripasudil for Fuchs’ Endothelial Corneal Dystrophy. jor. 2021;4(3):231-243. Accessed September 21, 2026. https://fortunejournals.org/ojs/index.php/jor/article/view/17409